| 1 | Approve Financial Statements and Statutory Reports
| Abstain |
| 2 | Approve Consolidated Financial Statements and Statutory Reports
| Abstain |
| 3 | Approve the Dividend | For |
| 4 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions
| For |
| 5 | Approve Compensation Report of Corporate Officers
| Oppose |
| 6 | Approve Compensation of Paul Hermelin, Chairman of the Board
| For |
| 7 | Approve Compensation of Aiman Ezzat, CEO
| Oppose |
| 8 | Approve Remuneration Policy of Chairman of the Board Until 19 May 2022
| Oppose |
| 9 | Approve Remuneration Policy of Chairman of the Board From 20 May 2022
| For |
| 10 | Approve Remuneration Policy of CEO
| Oppose |
| 11 | Approve Remuneration Policy of Directors
| For |
| 12 | Approve Remuneration of Directors in the Aggregate Amount of EUR 1.7 Million
| For |
| 13 | Elect Maria Ferraro - Non-Executive Director | For |
| 14 | Elect Olivier Roussat - Non-Executive Director | Abstain |
| 15 | Elect Paul Hermelin - Chair (Non Executive) | Abstain |
| 16 | Elect Xavier Musca - Non-Executive Director | For |
| 17 | Elect Frédéric Oudéa - Non-Executive Director | For |
| 18 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital
| Oppose |
| 19 | Amend Article 11 of Bylaws Re: Shares Held by Directors
| For |
| 20 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
| For |
| 21 | Authorize Capitalization of Reserves of Up to EUR 1.5 Billion for Bonus Issue or Increase in Par Value
| For |
| 22 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 540 Million
| For |
| 23 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 135 Million
| Oppose |
| 24 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 135 Million
| Oppose |
| 25 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights Under Items 23 and 24
| Oppose |
| 26 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above
| Oppose |
| 27 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| For |
| 28 | Authorize up to 1.2 Percent of Issued Capital for Use in Restricted Stock Plans Under Performance Conditions Reserved for Employees and Executive Officers
| Oppose |
| 29 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans
| Oppose |
| 30 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees of International Subsidiaries
| Oppose |
| 31 | Authorize Filing of Required Documents/Other Formalities
| For |
